Drospirenone/ethinylestradiol/levomefolic acid

From WikiMD's WELLNESSPEDIA

Ethinylestradiol

Combined oral contraceptive pill

Drospirenone/ethinylestradiol/levomefolic acid








Routes Oral























Drospirenone/ethinylestradiol/levomefolic acid is a combined oral contraceptive pill that contains three active ingredients: drospirenone, ethinylestradiol, and levomefolic acid. This combination is used primarily for birth control and to provide a supplemental source of folate.

Components[edit]

  • Drospirenone: A synthetic progestin that mimics the activity of the natural hormone progesterone. It helps to prevent ovulation and causes changes in the cervical mucus and uterine lining, making it harder for sperm to reach the uterus and for a fertilized egg to attach to the uterus.
  • Ethinylestradiol: A synthetic form of estrogen that works by inhibiting the release of gonadotropins from the pituitary gland, thereby preventing ovulation.
  • Levomefolic acid: The active form of folic acid, a B vitamin that is important for the production and maintenance of new cells. It helps to reduce the risk of neural tube defects in a developing fetus if pregnancy occurs.

Mechanism of Action[edit]

The combination of drospirenone and ethinylestradiol works by preventing ovulation (the release of an egg from an ovary). It also causes changes in the cervical mucus and the lining of the uterus to prevent sperm from reaching the egg and to prevent a fertilized egg from attaching to the uterus. Levomefolic acid provides a supplemental source of folate to help reduce the risk of neural tube defects in case of pregnancy.

Uses[edit]

Side Effects[edit]

Common side effects may include:

Serious side effects may include:

Contraindications[edit]

Related Pages[edit]


Sexual and reproductive health
Rights
Education
Planning
Contraception
Assisted
reproduction


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Drospirenone/ethinylestradiol/levomefolic_acid&oldid=5834458"